CA3036994A1 - Methode et systeme de caracterisations de panel - Google Patents
Methode et systeme de caracterisations de panel Download PDFInfo
- Publication number
- CA3036994A1 CA3036994A1 CA3036994A CA3036994A CA3036994A1 CA 3036994 A1 CA3036994 A1 CA 3036994A1 CA 3036994 A CA3036994 A CA 3036994A CA 3036994 A CA3036994 A CA 3036994A CA 3036994 A1 CA3036994 A1 CA 3036994A1
- Authority
- CA
- Canada
- Prior art keywords
- species
- panel
- genus
- taxa
- features
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 113
- 238000012512 characterization method Methods 0.000 title claims abstract description 110
- 244000005700 microbiome Species 0.000 claims abstract description 233
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 78
- 238000011282 treatment Methods 0.000 claims abstract description 36
- 239000012620 biological material Substances 0.000 claims abstract description 9
- 241000894007 species Species 0.000 claims description 230
- 239000006041 probiotic Substances 0.000 claims description 83
- 235000018291 probiotics Nutrition 0.000 claims description 83
- 239000000203 mixture Substances 0.000 claims description 48
- 239000012472 biological sample Substances 0.000 claims description 44
- 238000012545 processing Methods 0.000 claims description 35
- 230000000529 probiotic effect Effects 0.000 claims description 26
- 230000001737 promoting effect Effects 0.000 claims description 26
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 17
- 230000003321 amplification Effects 0.000 claims description 16
- 230000002974 pharmacogenomic effect Effects 0.000 claims description 15
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 239000003242 anti bacterial agent Substances 0.000 claims description 11
- 229940088710 antibiotic agent Drugs 0.000 claims description 11
- 239000003550 marker Substances 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 10
- 102000039446 nucleic acids Human genes 0.000 claims description 10
- 230000006872 improvement Effects 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 8
- 208000002551 irritable bowel syndrome Diseases 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 6
- 241000193749 Bacillus coagulans Species 0.000 claims description 5
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 5
- 241000193171 Clostridium butyricum Species 0.000 claims description 5
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 5
- 240000001929 Lactobacillus brevis Species 0.000 claims description 5
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 5
- 241000186842 Lactobacillus coryniformis Species 0.000 claims description 5
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 5
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 5
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 5
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 5
- 241000191996 Pediococcus pentosaceus Species 0.000 claims description 5
- 241000605861 Prevotella Species 0.000 claims description 5
- 229940054340 bacillus coagulans Drugs 0.000 claims description 5
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 5
- 229940012969 lactobacillus fermentum Drugs 0.000 claims description 5
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 5
- 241000813193 Acetobacter nitrogenifigens Species 0.000 claims description 4
- 241000589938 Azospirillum brasilense Species 0.000 claims description 4
- 241000194108 Bacillus licheniformis Species 0.000 claims description 4
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 4
- 241000193417 Brevibacillus laterosporus Species 0.000 claims description 4
- 241001136168 Clavibacter michiganensis Species 0.000 claims description 4
- 241000193163 Clostridioides difficile Species 0.000 claims description 4
- 241001026002 Enterococcus italicus Species 0.000 claims description 4
- 241001247311 Kocuria rhizophila Species 0.000 claims description 4
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 4
- 241000108055 Lactobacillus kefiranofaciens Species 0.000 claims description 4
- 241001339775 Lactobacillus kunkeei Species 0.000 claims description 4
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 4
- 241000194040 Lactococcus garvieae Species 0.000 claims description 4
- 241000194035 Lactococcus lactis Species 0.000 claims description 4
- 241000029588 Leptotrichia hofstadii Species 0.000 claims description 4
- 241000192005 Leuconostoc fallax Species 0.000 claims description 4
- 241000965142 Leuconostoc kimchii Species 0.000 claims description 4
- 241000202985 Methanobrevibacter smithii Species 0.000 claims description 4
- 208000008589 Obesity Diseases 0.000 claims description 4
- 241000192134 Oenococcus oeni Species 0.000 claims description 4
- 241000202302 Paenibacillus apiarius Species 0.000 claims description 4
- 241000186428 Propionibacterium freudenreichii Species 0.000 claims description 4
- 241000186812 Renibacterium salmoninarum Species 0.000 claims description 4
- 241000192026 Ruminococcus flavefaciens Species 0.000 claims description 4
- 241000192097 Staphylococcus sciuri Species 0.000 claims description 4
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 4
- 241000384856 Weissella koreensis Species 0.000 claims description 4
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 4
- 235000005911 diet Nutrition 0.000 claims description 4
- 230000037213 diet Effects 0.000 claims description 4
- 235000021061 dietary behavior Nutrition 0.000 claims description 4
- 239000006356 lactobacillus kefiranofaciens Substances 0.000 claims description 4
- 235000020824 obesity Nutrition 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 241001378512 Pseudoclavibacter helvolus Species 0.000 claims description 3
- 241000192031 Ruminococcus Species 0.000 claims description 3
- 241000194024 Streptococcus salivarius Species 0.000 claims description 3
- 235000006694 eating habits Nutrition 0.000 claims description 3
- 206010016766 flatulence Diseases 0.000 claims description 3
- 206010000060 Abdominal distension Diseases 0.000 claims description 2
- 206010000097 Abdominal tenderness Diseases 0.000 claims description 2
- 241000588626 Acinetobacter baumannii Species 0.000 claims description 2
- 241000702462 Akkermansia muciniphila Species 0.000 claims description 2
- 241000701474 Alistipes Species 0.000 claims description 2
- 241000521092 Alloprevotella Species 0.000 claims description 2
- 241000511612 Anaerofilum Species 0.000 claims description 2
- 241000428313 Anaerotruncus colihominis Species 0.000 claims description 2
- 208000019901 Anxiety disease Diseases 0.000 claims description 2
- 241000193755 Bacillus cereus Species 0.000 claims description 2
- 241000606125 Bacteroides Species 0.000 claims description 2
- 241000606124 Bacteroides fragilis Species 0.000 claims description 2
- 241000606215 Bacteroides vulgatus Species 0.000 claims description 2
- 241000927512 Barnesiella Species 0.000 claims description 2
- 241000186000 Bifidobacterium Species 0.000 claims description 2
- 241001608472 Bifidobacterium longum Species 0.000 claims description 2
- 241001202853 Blautia Species 0.000 claims description 2
- 241001216243 Butyricimonas Species 0.000 claims description 2
- 241000193174 Butyrivibrio crossotus Species 0.000 claims description 2
- 241000589876 Campylobacter Species 0.000 claims description 2
- 241000589877 Campylobacter coli Species 0.000 claims description 2
- 241000589875 Campylobacter jejuni Species 0.000 claims description 2
- 241000589986 Campylobacter lari Species 0.000 claims description 2
- 241000946390 Catenibacterium Species 0.000 claims description 2
- 241000755920 Christensenella Species 0.000 claims description 2
- 241000801624 Christensenella minuta Species 0.000 claims description 2
- 241000193403 Clostridium Species 0.000 claims description 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 2
- 241001464956 Collinsella Species 0.000 claims description 2
- 241001262170 Collinsella aerofaciens Species 0.000 claims description 2
- 206010010774 Constipation Diseases 0.000 claims description 2
- 241001464948 Coprococcus Species 0.000 claims description 2
- 241001464949 Coprococcus eutactus Species 0.000 claims description 2
- 208000011231 Crohn disease Diseases 0.000 claims description 2
- 241001535083 Dialister Species 0.000 claims description 2
- 241001624700 Dialister invisus Species 0.000 claims description 2
- 206010012735 Diarrhoea Diseases 0.000 claims description 2
- 241001608234 Faecalibacterium Species 0.000 claims description 2
- 241000605980 Faecalibacterium prausnitzii Species 0.000 claims description 2
- 241000605896 Fibrobacter succinogenes Species 0.000 claims description 2
- 241000662772 Flavonifractor Species 0.000 claims description 2
- 241000605909 Fusobacterium Species 0.000 claims description 2
- 241001143801 Gelria Species 0.000 claims description 2
- 241000606790 Haemophilus Species 0.000 claims description 2
- 241000862469 Holdemania Species 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 241000371451 Lactococcus fujiensis Species 0.000 claims description 2
- 241000785902 Odoribacter Species 0.000 claims description 2
- 241000843248 Oscillibacter Species 0.000 claims description 2
- 241000266824 Oscillospira Species 0.000 claims description 2
- 241000605936 Oxalobacter formigenes Species 0.000 claims description 2
- 241000160321 Parabacteroides Species 0.000 claims description 2
- 241001267970 Paraprevotella Species 0.000 claims description 2
- 241001607889 Peptoclostridium Species 0.000 claims description 2
- 241001464921 Phascolarctobacterium Species 0.000 claims description 2
- 241000280572 Pseudoflavonifractor Species 0.000 claims description 2
- 241000605947 Roseburia Species 0.000 claims description 2
- 241000192029 Ruminococcus albus Species 0.000 claims description 2
- 241000123753 Ruminococcus bromii Species 0.000 claims description 2
- 241000607142 Salmonella Species 0.000 claims description 2
- 241000533331 Salmonella bongori Species 0.000 claims description 2
- 241001138501 Salmonella enterica Species 0.000 claims description 2
- 241000607766 Shigella boydii Species 0.000 claims description 2
- 241000607764 Shigella dysenteriae Species 0.000 claims description 2
- 241000607762 Shigella flexneri Species 0.000 claims description 2
- 241000607760 Shigella sonnei Species 0.000 claims description 2
- 241000194017 Streptococcus Species 0.000 claims description 2
- 241000194042 Streptococcus dysgalactiae Species 0.000 claims description 2
- 241000194055 Streptococcus parauberis Species 0.000 claims description 2
- 241000194023 Streptococcus sanguinis Species 0.000 claims description 2
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 2
- 241001425419 Turicibacter Species 0.000 claims description 2
- 241000125947 Tyzzerella Species 0.000 claims description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 2
- 241001148134 Veillonella Species 0.000 claims description 2
- 241000607626 Vibrio cholerae Species 0.000 claims description 2
- 241000607447 Yersinia enterocolitica Species 0.000 claims description 2
- 241001464867 [Ruminococcus] gnavus Species 0.000 claims description 2
- 230000036506 anxiety Effects 0.000 claims description 2
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 2
- 208000024330 bloating Diseases 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 238000000513 principal component analysis Methods 0.000 claims description 2
- 238000007637 random forest analysis Methods 0.000 claims description 2
- 229940007046 shigella dysenteriae Drugs 0.000 claims description 2
- 229940115939 shigella sonnei Drugs 0.000 claims description 2
- 229940115920 streptococcus dysgalactiae Drugs 0.000 claims description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 2
- 229940118696 vibrio cholerae Drugs 0.000 claims description 2
- 229940098232 yersinia enterocolitica Drugs 0.000 claims description 2
- 241000604463 Desulfovibrio piger Species 0.000 claims 1
- 241001657509 Eggerthella Species 0.000 claims 1
- 241001333951 Escherichia coli O157 Species 0.000 claims 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 1
- 208000000913 Kidney Calculi Diseases 0.000 claims 1
- 206010029148 Nephrolithiasis Diseases 0.000 claims 1
- 208000001280 Prediabetic State Diseases 0.000 claims 1
- 230000036996 cardiovascular health Effects 0.000 claims 1
- 238000010197 meta-analysis Methods 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
- 230000008569 process Effects 0.000 description 37
- 230000006870 function Effects 0.000 description 24
- 238000005516 engineering process Methods 0.000 description 19
- 230000002068 genetic effect Effects 0.000 description 18
- 108090000623 proteins and genes Proteins 0.000 description 18
- 239000000523 sample Substances 0.000 description 17
- 230000000875 corresponding effect Effects 0.000 description 16
- 210000001035 gastrointestinal tract Anatomy 0.000 description 16
- 238000012163 sequencing technique Methods 0.000 description 12
- 239000003814 drug Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 238000005457 optimization Methods 0.000 description 9
- 108091093088 Amplicon Proteins 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 108020004465 16S ribosomal RNA Proteins 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 230000002123 temporal effect Effects 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000000090 biomarker Substances 0.000 description 4
- 238000004422 calculation algorithm Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 108091036078 conserved sequence Proteins 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 235000021110 pickles Nutrition 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000015943 Coeliac disease Diseases 0.000 description 2
- 208000027244 Dysbiosis Diseases 0.000 description 2
- 238000007397 LAMP assay Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000007140 dysbiosis Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 244000005702 human microbiome Species 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000092 prognostic biomarker Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 235000021108 sauerkraut Nutrition 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 238000009966 trimming Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000050 Abdominal adhesions Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000186650 Clavibacter Species 0.000 description 1
- 206010010539 Congenital megacolon Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000605716 Desulfovibrio Species 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 208000021584 Expressive language disease Diseases 0.000 description 1
- 208000034347 Faecal incontinence Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 208000004592 Hirschsprung disease Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000009608 Papillomavirus Infections Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 208000032128 Phonological disease Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010040550 Shigella infections Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000028790 Speech Sound disease Diseases 0.000 description 1
- 208000032124 Squamous Intraepithelial Lesions Diseases 0.000 description 1
- 208000003028 Stuttering Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 208000037009 Vaginitis bacterial Diseases 0.000 description 1
- 208000027207 Whipple disease Diseases 0.000 description 1
- 201000008629 Zollinger-Ellison syndrome Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000030137 articulation disease Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 229940015062 campylobacter jejuni Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000013145 classification model Methods 0.000 description 1
- 238000002052 colonoscopy Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000000104 diagnostic biomarker Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000007784 diverticulitis Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 201000000052 gastrinoma Diseases 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000007849 hot-start PCR Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 208000021145 human papilloma virus infection Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 235000015141 kefir Nutrition 0.000 description 1
- 235000019226 kombucha tea Nutrition 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 238000003058 natural language processing Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000011338 personalized therapy Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 208000014081 polyp of colon Diseases 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002579 sigmoidoscopy Methods 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000007862 touchdown PCR Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000002609 virtual colonoscopy Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/30—Data warehousing; Computing architectures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Primary Health Care (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
Abstract
Certains modes de réalisation d'un système et d'une méthode de caractérisation d'un panel de conditions associées à un ensemble de taxa relatifs à des micro-organismes peuvent faire appel à une base de données taxinomique comprenant des caractéristiques de microbiome de référence concernant l'ensemble de taxa associé au panel de conditions ; un système de manipulation pouvant servir à collecter un contenant comprenant un matériel biologique provenant d'un utilisateur, le système de manipulation comprenant un système séquenceur pouvant servir à déterminer un ensemble de données de séquences de micro-organismes ; et un système de caractérisation de panel pouvant servir à : déterminer des caractéristiques de microbiome d'utilisateur de l'ensemble de taxa pour l'utilisateur sur la base de l'ensemble de données de séquences de micro-organismes, générer une comparaison entre les caractéristiques de microbiome d'utilisateur et les caractéristiques de microbiome de référence, et déterminer une caractérisation de panel du panel de conditions pour l'utilisateur sur la base de la comparaison ; et un système de traitement pouvant servir à promouvoir une thérapie pour une condition du panel de conditions sur la base de la caractérisation de panel.
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662395939P | 2016-09-16 | 2016-09-16 | |
| US62/395,939 | 2016-09-16 | ||
| US15/606,743 | 2017-05-26 | ||
| US15/606,743 US10803991B2 (en) | 2014-10-21 | 2017-05-26 | Method and system for microbiome-derived diagnostics and therapeutics |
| US201762520058P | 2017-06-15 | 2017-06-15 | |
| US62/520,058 | 2017-06-15 | ||
| US201762525379P | 2017-06-27 | 2017-06-27 | |
| US62/525,379 | 2017-06-27 | ||
| PCT/US2017/052098 WO2018053443A1 (fr) | 2016-09-16 | 2017-09-18 | Méthode et système de caractérisations de panel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3036994A1 true CA3036994A1 (fr) | 2018-03-22 |
Family
ID=61619786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3036994A Pending CA3036994A1 (fr) | 2016-09-16 | 2017-09-18 | Methode et systeme de caracterisations de panel |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP3512421A4 (fr) |
| JP (1) | JP7114091B2 (fr) |
| KR (1) | KR102486181B1 (fr) |
| CN (1) | CN109715059A (fr) |
| AU (1) | AU2017326564A1 (fr) |
| BR (1) | BR112019005025A8 (fr) |
| CA (1) | CA3036994A1 (fr) |
| CO (1) | CO2019003713A2 (fr) |
| SG (1) | SG11201901726QA (fr) |
| WO (1) | WO2018053443A1 (fr) |
| ZA (1) | ZA201901371B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109943636B (zh) * | 2019-04-11 | 2020-01-24 | 上海宝藤生物医药科技股份有限公司 | 一种结直肠癌微生物标志物及其应用 |
| CN110669818B (zh) * | 2019-10-30 | 2021-08-24 | 中南大学 | 多发性骨髓瘤肠道微生物标志物及应用和检测制剂 |
| KR102373889B1 (ko) * | 2020-01-23 | 2022-03-15 | 주식회사 에이치이엠파마 | 장내 환경 개선을 위한 맞춤형 솔루션을 제공하는 방법 및 서버 |
| WO2022160358A1 (fr) * | 2021-02-01 | 2022-08-04 | 苏州大学附属儿童医院 | Utilisation de micro-organisme intestinal comme marqueur de dysplasie broncho-pulmonaire chez un nourrisson prématuré |
| EP4288559B1 (fr) * | 2021-02-03 | 2025-11-26 | Tata Consultancy Services Limited | Procédé et système pour concevoir des agents thérapeutiques personnalisés et un régime sur la base de fonctions du microbiome |
| KR102304402B1 (ko) * | 2021-03-26 | 2021-09-24 | 주식회사 에이치이엠파마 | 머신러닝 모델을 이용하여 비만 여부를 판별하는 방법 및 진단 장치 |
| EP4411742A4 (fr) | 2021-09-29 | 2025-01-08 | FUJIFILM Corporation | Procédé de sélection de caractéristique mesurable et préférable, programme pour sélectionner une caractéristique mesurable et préférable, et dispositif de sélection de caractéristique mesurable et préférable |
| WO2023171482A1 (fr) | 2022-03-09 | 2023-09-14 | 富士フイルム株式会社 | Procédé, dispositif et programme |
| CN117838736B (zh) * | 2024-01-29 | 2024-06-14 | 吉林省农业科学院(中国农业科技东北创新中心) | 凝结芽孢杆菌ja845在制备预防和/或治疗抗动脉粥样硬化药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9848760B2 (en) | 2009-06-29 | 2017-12-26 | Gearbox, Llc | Devices for continual monitoring and introduction of gastrointestinal microbes |
| GB2535034A (en) | 2013-07-21 | 2016-08-10 | Whole Biome Inc | Methods and systems for microbiome characterization, monitoring and treatment |
| EP2876167A1 (fr) * | 2013-11-21 | 2015-05-27 | Institut Gustave Roussy | Composition de la flore microbienne, comme marqueur de la réceptivité à la chimiothérapie et utilisation de modulateurs microbiens (pré-, pro- ou synbiotiques) pour améliorer l'efficacité d'un traitement du cancer |
| AU2015209718B2 (en) * | 2014-01-25 | 2021-03-25 | Macrogen Inc. | Method and system for microbiome analysis |
| US9703929B2 (en) * | 2014-10-21 | 2017-07-11 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
| EP3283085A4 (fr) * | 2015-04-13 | 2019-04-10 | Ubiome, Inc. | Procédé et système pour diagnostics et thérapies dérivés du microbiome pour affections associées à des éléments taxonomiques du microbiome |
-
2017
- 2017-09-18 SG SG11201901726QA patent/SG11201901726QA/en unknown
- 2017-09-18 EP EP17851735.5A patent/EP3512421A4/fr active Pending
- 2017-09-18 CN CN201780057144.2A patent/CN109715059A/zh active Pending
- 2017-09-18 AU AU2017326564A patent/AU2017326564A1/en not_active Abandoned
- 2017-09-18 KR KR1020197010012A patent/KR102486181B1/ko active Active
- 2017-09-18 JP JP2019514295A patent/JP7114091B2/ja active Active
- 2017-09-18 CA CA3036994A patent/CA3036994A1/fr active Pending
- 2017-09-18 BR BR112019005025A patent/BR112019005025A8/pt not_active Application Discontinuation
- 2017-09-18 WO PCT/US2017/052098 patent/WO2018053443A1/fr not_active Ceased
-
2019
- 2019-03-05 ZA ZA201901371A patent/ZA201901371B/en unknown
- 2019-04-12 CO CONC2019/0003713A patent/CO2019003713A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3512421A4 (fr) | 2021-08-11 |
| JP2019528729A (ja) | 2019-10-17 |
| BR112019005025A2 (pt) | 2019-06-18 |
| WO2018053443A1 (fr) | 2018-03-22 |
| EP3512421A1 (fr) | 2019-07-24 |
| SG11201901726QA (en) | 2019-03-28 |
| CO2019003713A2 (es) | 2019-04-30 |
| AU2017326564A1 (en) | 2019-03-28 |
| KR20190055127A (ko) | 2019-05-22 |
| JP7114091B2 (ja) | 2022-08-08 |
| BR112019005025A8 (pt) | 2023-03-21 |
| CN109715059A (zh) | 2019-05-03 |
| ZA201901371B (en) | 2019-11-27 |
| KR102486181B1 (ko) | 2023-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102486181B1 (ko) | 패널 특성화를 위한 방법 및 시스템 | |
| US11783914B2 (en) | Method and system for panel characterizations | |
| US11001900B2 (en) | Method and system for characterization for female reproductive system-related conditions associated with microorganisms | |
| US10246753B2 (en) | Method and system for characterizing mouth-associated conditions | |
| US10795972B2 (en) | Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions | |
| JP2020532979A (ja) | 微生物に関連する女性生殖器系関連状態の特徴解析のための方法及びシステム | |
| US20190172555A1 (en) | Method and system for microbiome-derived diagnostics and therapeutics for oral health | |
| US20190085396A1 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with gastrointestinal health | |
| AU2022202660A1 (en) | Method and system for characterization for appendix-related conditions associated with microorganisms | |
| CN109475305B (zh) | 用于微生物药物基因组学的方法和系统 | |
| US11773455B2 (en) | Method and system for microbiome-derived diagnostics and therapeutics infectious disease and other health conditions associated with antibiotic usage | |
| US20180342322A1 (en) | Method and system for characterization for appendix-related conditions associated with microorganisms | |
| EP3426794A1 (fr) | Procédé et système de caractérisation d'états pathologiques associés à la bouche | |
| CN107849609B (zh) | 用于心理健康相关状况的微生物组来源的诊断和治疗的方法及系统 | |
| US20190211378A1 (en) | Method and system for microbiome-derived diagnostics and therapeutics for cerebro-craniofacial health | |
| CN107835859B (zh) | 用于运动系统状况的微生物组来源的诊断和治疗的方法及系统 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20210111 |
|
| FZDC | Discontinued application reinstated |
Effective date: 20210512 |
|
| EEER | Examination request |
Effective date: 20211129 |
|
| EEER | Examination request |
Effective date: 20211129 |
|
| EEER | Examination request |
Effective date: 20211129 |
|
| EEER | Examination request |
Effective date: 20211129 |
|
| EEER | Examination request |
Effective date: 20211129 |
|
| EEER | Examination request |
Effective date: 20211129 |
|
| EEER | Examination request |
Effective date: 20211129 |